Medi-Caps (NSE:MEDICAPQ) Cyclically Adjusted PS Ratio: (As of Aug. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:MEDICAPQ Medi-Caps Ltd NSE:MEDICAPQ
41 GF Score
Price ₹23.56
GF Value ₹19.30
Valuation Modestly Overvalued
! 3 Warning Signs
View Full Analysis

What is Medi-Caps Cyclically Adjusted PS Ratio?

Note: If the price history is too short, we do not calculate current Cyclically Adjusted PS Ratio for this stock. All the historical data is shown as the company's primary share's data instead.

Shiller PE for Stocks: The True Measure of Stock Valuation


Medi-Caps  (NSE:MEDICAPQ) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Medi-Caps Cyclically Adjusted PS Ratio Related Terms


Medi-Caps Cyclically Adjusted PS Ratio Historical Data

* Premium members only.

The historical data trend for Medi-Caps's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medi-Caps Cyclically Adjusted PS Ratio Chart

Medi-Caps Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.93 0.55

Medi-Caps Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.95 0.85 0.73 0.55 0.63

NSE:MEDICAPQ vs : Cyclically Adjusted PS Ratio Comparison

For the Real Estate - Diversified subindustry, Medi-Caps's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medi-Caps Cyclically Adjusted PS Ratio vs Real Estate Industry

For the Real Estate industry and Real Estate sector, Medi-Caps's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Medi-Caps's Cyclically Adjusted PS Ratio falls into.


NSE:MEDICAPQ
41GF Score
Medi-Caps Ltd NSE:MEDICAPQ
Cyclically Adjusted PS Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medi-Caps Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Medi-Caps's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 is calculated as:

For example, Medi-Caps's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=2.178/333.9520*333.9520
=2.178

Current CPI (Jun. 2026) = 333.9520.

Medi-Caps Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201212 6.693 229.601 9.735
201303 7.079 232.773 10.156
201403 0.000 236.293 0.000
201503 0.000 236.119 0.000
201603 0.000 238.132 0.000
201703 0.000 243.801 0.000
201803 0.000 249.554 0.000
201806 6.324 251.989 8.381
201809 12.551 252.439 16.604
201812 10.677 251.233 14.192
201903 12.116 254.202 15.917
201906 12.654 256.143 16.498
201909 8.770 256.759 11.407
201912 6.759 256.974 8.784
202003 4.739 258.115 6.131
202006 13.243 257.797 17.155
202009 13.889 260.280 17.820
202012 14.567 260.474 18.676
202103 9.799 264.877 12.354
202106 13.751 271.696 16.902
202109 13.837 274.310 16.846
202112 13.855 278.802 16.596
202203 13.274 287.504 15.418
202206 9.925 296.311 11.186
202209 12.344 296.808 13.889
202212 8.746 296.797 9.841
202303 8.115 301.836 8.978
202306 4.980 305.109 5.451
202309 4.640 307.789 5.034
202312 5.482 306.746 5.968
202403 5.995 312.332 6.410
202406 4.969 314.175 5.282
202409 6.632 315.301 7.024
202412 3.215 315.605 3.402
202503 5.569 319.799 5.815
202506 2.146 322.561 2.222
202509 1.607 324.800 1.652
202512 3.419 324.054 3.523
202603 2.745 330.213 2.776
202606 2.178 333.952 2.178

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Medi-Caps (NSE:MEDICAPQ) Overvalued in 2026?

Based on GuruFocus' analysis, Medi-Caps stock appears to be overvalued. The current stock price of ₹23.56 is trading 22.1% above its estimated GF Value™ of ₹19.30. GuruFocus considers Medi-Caps to be Modestly Overvalued.

Key valuation signals for NSE:MEDICAPQ:

  • Cyclically Adjusted PS Ratio:
  • GF Value™: ₹19.30 vs. price of ₹23.56 (22.1% above fair value)
  • GF Score™: 41/100 with 3 warning signs

No single metric tells the full story. See the NSE:MEDICAPQ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medi-Caps Business Description

Comparable Companies
Other Exchanges 523144:India
Address 201, Pushpratna Paradise, 9/5, New Palasia, Opposite UCO Bank, Indore, MP, IND, 452 001
Medi-Caps Ltd is an India-based company engaged in the real estate business witch city centric developments by way of Strategic Land acquisition and developing the residential and commercial properties. Its project include Medicaps Business Park. The group has two segments namely, the Pharma Division, and the Real Estate Division. The majority of its revenue is generated from the Pharma Division.
41GF Score

Get the complete analysis for NSE:MEDICAPQ

Cyclically Adjusted PS Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹23.56
Price
₹19.30
GF Value